Blog

China's drug administration law and serialization framework for medicines could affect your China product packaging strategy. Learn how today.

Review the different approaches healthcare organizations can take to achieve DSCSA compliance.

Companies that sell product into Russia need to focus on six critical considerations, and understand how Russia challenges differ from those of FMD…

Understand the challenges small pharmas face as serialization approaches, and how industry expert Altran helps solve them.

View a compilation of the most recent track and trace regulations for the healthcare supply chain in Saudi Arabia. Get insights into compliance.

Discover what language the new unique identifier needs to be in on your medicine packs, depending on which European market you ship to.

See why clinical-stage pharma companies must learn basic DSCSA serialization requirements—or risk years of work and millions of dollars.

DSCSA isn't just a requirement for your retail pharmacy, it's an opportunity. Watch this supply chain transformation video to find out why.

Get insights into how much serialization will really cost your company. Proven serialization solution providers can help identify additional costs.

Stockpiling product to delay EU FMD compliance is a temporary approach that offers no long-term value—and carries significant risks.

Here are 5 questions to ask yourself when creating a strategy for serial number aggregation that will set you up for long-term success.

View a compilation of the most recent track and trace regulations for the healthcare supply chain in the U.S. Get insights into DSCSA compliance.